Qilu Hospital of Shandong University

- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Spironolactone Improved Children With NCOR Mutations
- Conditions
- NCOR Gene MutationsSpironolactoneASD
- Interventions
- Drug: .spironolactone
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 3
- Registration Number
- NCT06678685
Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department
- Conditions
- Chest PainAcute Coronary Syndrome
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 8000
- Registration Number
- NCT06669884
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
- Conditions
- Bladder Cancer
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 293
- Registration Number
- NCT06662071
- Locations
- 🇨🇳
Binzhou Medical University Hospital, Binzhou, Shandong, China
🇨🇳Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, China
🇨🇳Qilu Hospital of Shandong University, Jinan, Shandong, China
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
- Conditions
- Endometrial Cancer
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 42
- Registration Number
- NCT06656949
- Locations
- 🇨🇳
Qilu Hospital,Shandong University, Jinan, Shandong, China
Cardiovascular Ultrasound for the Rehabilitation of Patients With Coronary Heart Disease After PCI
- Conditions
- Coronary Heart Disease
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT06640400
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinnan, Shandong, China
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
- Conditions
- Stage II-III Gastric Cancer
- Interventions
- Drug: Standard chemotherapy regimen
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 197
- Registration Number
- NCT06609759
- Locations
- 🇨🇳
Qilu Hospital of Shandong Univertisy, Jinan, Shandong, China
🇨🇳Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳Jinan Central Hospital,, Jinan, Shandong, China
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
- Conditions
- ImmunotherapyCarcinoma, Hepatocellular
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT06571396
- Locations
- 🇨🇳
Qilu hospital of Shandong university, Jinan, Shandong, China
Neoadjuvant Therapy in Cervical Cancer
- Conditions
- Uterine Cervical Neoplasms
- Interventions
- Drug: Disitamab Vedotin and Cisplatin
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 48
- Registration Number
- NCT06558682
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Efficacy of Sacral Nerve Modulation on Urinary and Defecation Dysfunction After Spinal Cord Injury:A Prospective, Single-arm Study
- Conditions
- CystometryUltrasoundSacral Neuromodulation
- Interventions
- Device: sacral neuromodulation
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 41
- Registration Number
- NCT06553469
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness
- Conditions
- Acute Febrile Illness
- Interventions
- Other: Infection
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 900
- Registration Number
- NCT06552975
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China